EVs in Treatment of Lung Diseases and Other Targets

Wednesday, 3 April 2024 at 11:00

Add to Calendar ▼2024-04-03 11:00:002024-04-03 12:00:00Europe/LondonEVs in Treatment of Lung Diseases and Other TargetsExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, Therapeutics in Miami, FloridaMiami, FloridaSELECTBIOenquiries@selectbiosciences.com

Marcin Jurga, Chief Scientific Officer, EXO Biologics SA

Marcin Jurga

Marcin Jurga, PhD, CSO at EXO Biologics, has been working in the fields of cell-based regenerative medicine and tissue engineering for over 20 years. Marcin Jurga has been leading teams developing EVs drug candidates since 2011.